Ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added boost to the <a target=_blan ...

Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform, today announced the ...

In addition, several circulating biomarkers are useful in the diagnosis and management of heart failure. Cardiac biomarkers, specifically cardiac troponin, are essential for the identification of ...

In this article, the authors will focus on cardiac, neurological and inflammatory biomarkers as potential predictors of outcome after CA. Complex and multifactorial mechanisms contribute to worsen ...

Biomarkers may includes antigens, DNA, mRNA, and enzymes. Cardiac biomarkers are part of the standards of care and guidelines for myocardial infarction and heart failure. Cardiac biomarkers represent ...

Abstract: Quantum-dot Linked Immuno-Detection Assay, or QLIDA-based tests are inexpensive, fast, and highly sensitive and can quantitatively detect biomarkers in a wide concentration range, and ...

Explore how circulating cell-free plasma telomere length (cf-TL) serves as a promising biomarker for heart failure.

Mavacamten is a cardiac myosin inhibitor already approved for treating hypertrophic cardiomyopathy (HCM) and has demonstrated ...

AFICAMTEN was found to be a safe and effective treatment for symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), ...

According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...

Weight loss via lifestyle intervention can change cardiac biomarkers A secondary analysis of the LookAHEAD trial showed that lifestyle interventions targeting weight loss for type 2 diabetes ...

The pathophysiology of pre-eclampsia has traditionally been thought to result from placental dysfunction; however, a ...